Showing 861-880 of 7110 for: Cochrane Systematic Reviews Back
- Benzodiazepines for neuroleptic-induced acute akathisia
Cochrane Systematic Reviews, 22-Oct-2008
Neuroleptic-induced akathisia is one of the most common and distressing early-onset adverse effects of antipsychotic drugs, being associated with poor compliance with treatment, and thus, ultimately, to an increase risk of relapse. This review assesses th
- Benzodiazepines for neuroleptic-induced tardive dyskinesia
Cochrane Systematic Reviews, 18-Jan-2012
Tardive dyskinesia (TD) is a disfiguring movement disorder, often of the orofacial region, frequently caused by the use of neuroleptic drugs. A wide range of strategies have been used to help manage tardive dyskinesia, and for those who are unable to have
- Benzodiazepines for psychosis-induced aggression or agitation
Cochrane Systematic Reviews, 26-Mar-2013
Acute psychotic illness, especially when associated with agitated or violent behaviour, can require urgent pharmacological tranquillisation or sedation. In several countries, clinicians often use benzodiazepines (either alone or in combination with antips
- Benzodiazepines for schizophrenia
Cochrane Systematic Reviews, 2-Oct-2012
Because of the high number of people with schizophrenia not responding adequately to monotherapy with antipsychotic agents, the evidence regarding the efficacy and safety of additional medication was examined in a number of clinical trials. One approach t
- Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults
Cochrane Systematic Reviews, 7-Feb-2011
Breathlessness is one of the most common symptoms experienced in the advanced stages of malignant and non-malignant disease. Benzodiazepines are widely used for the relief of breathlessness in advanced diseases and are regularly recommended in the literat
- Benzo-pyrones for reducing and controlling lymphoedema of the limbs
Cochrane Systematic Reviews, 10-Sep-2015
Lymphoedema is the accumulation of excess fluid in the body caused by obstruction of the lymphatic drainage mechanisms. Treatment with Benzo-pyrones is thought to reduce fluid forming in the subcutaneous tissues and reduce pain and discomfort of the affec
- Beta blockers for peripheral arterial disease
Cochrane Systematic Reviews, 11-Sep-2013
Beta (ß) blockers are indicated for use in coronary artery disease (CAD). However, optimal therapy for people with CAD accompanied by intermittent claudication has been controversial because of the presumed peripheral haemodynamic consequences of beta blo
- Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
Cochrane Systematic Reviews, 6-Jan-2014
Optimal antibiotic treatment for sepsis is imperative. Combining a beta lactam antibiotic with an aminoglycoside antibiotic may provide certain advantages over beta lactam monotherapy.
- Beta radiation for glaucoma surgery
Cochrane Systematic Reviews, 10-May-2012
The outcome of glaucoma surgery can be affected by the rate at which the surgical wound heals. Beta radiation has been proposed as a rapid and simple treatment to slow down the healing response.
- Beta2-adrenoceptor agonists for dysmenorrhoea
Cochrane Systematic Reviews, 19-Apr-2012
Dysmenorrhoea is a common gynaecological complaint that can affect as many as 50% of premenopausal women, 10% of whom suffer severely enough to be rendered incapacitated for one to three days during each menstrual cycle. Primary dysmenorrhoea is where wom
- Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis
Cochrane Systematic Reviews, 30-Aug-2015
The diagnosis of acute bronchitis is made on clinical grounds and a variety of clinical definitions have been used. There are no clearly effective treatments for the cough of acute bronchitis. Beta2-agonists are often prescribed, perhaps because clinician
- Beta2-agonists for exercise-induced asthma
Cochrane Systematic Reviews, 26-Sep-2013
It is well known that physical exercise can trigger asthma symptoms and can induce bronchial obstruction in people without clinical asthma. International guidelines on asthma management recommend the use of beta2-agonists at any stage of the disease. At p
- Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery
Cochrane Systematic Reviews, 12-Jan-2015
People undergoing major vascular surgery have an increased risk of postoperative cardiac complications. Beta-adrenergic blockers represent an important and established pharmacological intervention in the prevention of cardiac complications in people with
- Beta-blocker supplementation of standard drug treatment for schizophrenia
Cochrane Systematic Reviews, 15-Jun-2010
Many people with schizophrenia or similar severe mental disorders do not achieve a satisfactory treatment response with ordinary antipsychotic drug treatment. In these cases, various add-on medications are used, amongst them beta-adrenergic receptor antag
- Beta-blocker therapy for tremor in Parkinson's disease
Cochrane Systematic Reviews, 11-Nov-2008
The tremor of Parkinson's disease can cause considerable disability for the individual concerned. Traditional antiparkinsonian therapies such as levodopa have only a minor effect on tremor. Beta-blockers are used to attenuate other forms of tremor such as
- Beta‐blockers for congestive heart failure in children
Cochrane Systematic Reviews, 23-Jul-2020
Beta-blockers are an essential part of standard therapy in adult congestive heart failure and therefore, are expected to be beneficial in children. However, congestive heart failure in children differs from that in adults in terms of characteristics, aeti
- Beta-blockers for hypertension
Cochrane Systematic Reviews, 27-Aug-2012
This review is an update of the Cochrane Review published in 2007, which assessed the role of beta-blockade as first-line therapy for hypertension.
- Beta-blockers for preventing stroke recurrence
Cochrane Systematic Reviews, 15-Oct-2014
Stroke affects 15 million people per year worldwide. Despite recent developments in acute stroke treatment, prevention remains very important. Stroke has a high rate of recurrence; therefore secondary prevention is also important. Many clinical approaches
- Betahistine for Ménière's disease or syndrome
Cochrane Systematic Reviews, 7-Feb-2011
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 1, 2001 and previously updated in 2008.
- Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
Cochrane Systematic Reviews, 11-Feb-2015
Continued controversy surrounds the optimal empirical treatment for febrile neutropenia. New broad-spectrum beta-lactams have been introduced as single treatment, and classically, a combination of a beta-lactam with an aminoglycoside has been used.
